These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29575905)

  • 1. Efficient ZFN-Mediated Stop Codon Integration into the CCR5 Locus in Hematopoietic Stem Cells: A Possible Source for Intrabone Marrow Cell Transplantation.
    Chattong S; Chaikomon K; Chaiya T; Tangkosakul T; Palavutitotai N; Anusornvongchai T; Manotham K
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):575-579. PubMed ID: 29575905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of CCR5-defective CD34 cells from ZFN-driven stop codon-integrated mesenchymal stem cell clones.
    Manotham K; Chattong S; Setpakdee A
    J Biomed Sci; 2015 Mar; 22(1):25. PubMed ID: 25890320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
    Tebas P; Stein D; Tang WW; Frank I; Wang SQ; Lee G; Spratt SK; Surosky RT; Giedlin MA; Nichol G; Holmes MC; Gregory PD; Ando DG; Kalos M; Collman RG; Binder-Scholl G; Plesa G; Hwang WT; Levine BL; June CH
    N Engl J Med; 2014 Mar; 370(10):901-10. PubMed ID: 24597865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
    Allers K; Schneider T
    Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates.
    Peterson CW; Wang J; Norman KK; Norgaard ZK; Humbert O; Tse CK; Yan JJ; Trimble RG; Shivak DA; Rebar EJ; Gregory PD; Holmes MC; Kiem HP
    Blood; 2016 May; 127(20):2416-26. PubMed ID: 26980728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CCR5 Gene Edited CD34
    Karuppusamy KV; Demosthenes JP; Venkatesan V; Christopher AC; Babu P; Azhagiri MK; Jacob A; Ramalingam VV; Rangaraj S; Murugesan MK; Marepally SK; Varghese GM; Srivastava A; Kannangai R; Thangavel S
    Front Immunol; 2022; 13():792684. PubMed ID: 35359982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
    Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
    Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
    Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
    Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
    Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
    Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice.
    Hofer U; Henley JE; Exline CM; Mulhern O; Lopez E; Cannon PM
    J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S160-4. PubMed ID: 24151324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.
    van Rensburg R; Beyer I; Yao XY; Wang H; Denisenko O; Li ZY; Russell DW; Miller DG; Gregory P; Holmes M; Bomsztyk K; Lieber A
    Gene Ther; 2013 Feb; 20(2):201-14. PubMed ID: 22436965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
    Lai Y
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV.
    Almeida MJ; Matos A
    Curr HIV Res; 2019; 17(5):306-323. PubMed ID: 31652113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids.
    Schleifman EB; Bindra R; Leif J; del Campo J; Rogers FA; Uchil P; Kutsch O; Shultz LD; Kumar P; Greiner DL; Glazer PM
    Chem Biol; 2011 Sep; 18(9):1189-98. PubMed ID: 21944757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.
    Sather BD; Romano Ibarra GS; Sommer K; Curinga G; Hale M; Khan IF; Singh S; Song Y; Gwiazda K; Sahni J; Jarjour J; Astrakhan A; Wagner TA; Scharenberg AM; Rawlings DJ
    Sci Transl Med; 2015 Sep; 7(307):307ra156. PubMed ID: 26424571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
    Yao Y; Nashun B; Zhou T; Qin L; Qin L; Zhao S; Xu J; Esteban MA; Chen X
    Hum Gene Ther; 2012 Feb; 23(2):238-42. PubMed ID: 21981760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 Infection.
    Romito M; Juillerat A; Kok YL; Hildenbeutel M; Rhiel M; Andrieux G; Geiger J; Rudolph C; Mussolino C; Duclert A; Metzner KJ; Duchateau P; Cathomen T; Cornu TI
    Biotechnol J; 2021 Jan; 16(1):e2000023. PubMed ID: 33103367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
    Xu L; Wang J; Liu Y; Xie L; Su B; Mou D; Wang L; Liu T; Wang X; Zhang B; Zhao L; Hu L; Ning H; Zhang Y; Deng K; Liu L; Lu X; Zhang T; Xu J; Li C; Wu H; Deng H; Chen H
    N Engl J Med; 2019 Sep; 381(13):1240-1247. PubMed ID: 31509667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
    Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
    AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.